MEMedpace MEDP · NASDAQ
$619.66 +0.19% (+$1.19)
- Market cap
- $17.3B
- Enterprise value
- $16.9B
- P/E
- 35.2x
- Forward P/E
- 33.3x
- PEG
- 3.3x
- P/S
- 6.2x
- P/FCF
- 23.6x
- EV/EBITDA
- 28.1x
- ROIC
- 77.0%
- Bruto marža
- 28.8%
- Neto marža
- 17.7%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -0.6x
- Beta
- 1.18
- Free float
- 81.2%
O podjetju
Medpace Holdings, Inc. (MEDP) is a global company specializing in clinical research and the development of drugs and medical devices. With over twenty years of experience in the field, Medpace provides comprehensive clinical trial services for pharmaceutical and biotechnology companies. The company is known for its expertise, technological innovation, and commitment to ensuring high-quality and safe pharmaceutical products. Medpace Holdings, Inc. (MEDP) shares could be suitable for investors looking to invest in a company playing a key role in clinical research and the development of drugs and medical devices.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
August James Troendle
Employees
6,500
Headquarters
Cincinnati
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke